Upton-Dingell Opioid Legislation Advances
Bipartisan bill moves through Committee to House Floor, will spur development of non-addictive pain medications
U.S. Rep. Fred Upton, R-St. Joseph, and U.S. Rep. Debbie Dingell, D-Dearborn, today joined the majority of their colleagues on the Energy and Commerce Committee in voting to advance their bipartisan legislation H.R. 5002, the Advancing Cutting-Edge (ACE) Research Act. The bill passed unanimously and now heads to the House Floor for consideration.
“I’m pleased to see the ACE Research Act – a bipartisan bill my colleague Debbie Dingell and I have worked on – advance today,” said Upton. “This balanced bill better allows the NIH to partner with innovative companies doing cutting-edge research to address to the tragic opioid epidemic and get non-addictive pain medications to those in need. We’ve had major responses to the opioid crisis in recent years, but more work remains. We urge our leadership here in the House to bring this bill up for a vote quickly. There isn’t time to waste.”
“I have lived all sides of the opioid epidemic – my father was addicted to opioids before anyone really knew what they were and my sister died of a drug overdose. Yet my husband lives with chronic pain and needs opioids to live comfortably,” said Dingell. “We cannot let the pendulum swing too far in either direction and we cannot be denying medication from those who need it. This bill will allow the NIH to innovate and partner with new entities conducting cutting-edge medical research so we can develop new non-addictive painkillers – giving people the relief they need from crippling pain while helping to prevent addiction from taking hold of families in the first place.”
Developing new, non-addictive pain medications is essential to combating the opioid epidemic. During Congressional hearings Dr. Francis Collins, Director of the National Institutes of Health (NIH), requested the agency be given more flexibility, known as other transaction authority (OTA), so the agency could better partner with innovative companies doing research to address the opioid epidemic and other public health threats. Under the ACE Research Act, the NIH Director will be able to more quickly support research on new, non-addictive pain medications and other emerging technologies that can offer hope to those suffering from opioid addiction.
Senators Lamar Alexander (TN) and Patty Murray (WA), the Chairman and Ranking Member of the Senate Committee on Health, Education, Labor, and Pensions, have introduced companion legislation in the U.S. Senate (S.2406).